Introduction: Who Should Undergo Diagnostics and When

Not everyone with Waldenstrom’s macroglobulinaemia experiences symptoms right away. In fact, about one in four people discover they have this condition during routine medical visits for completely different reasons. This happens because the disease grows slowly, and early changes in blood cells may only show up through standard blood work done for other health checks.^[2]

You should consider seeking diagnostic testing if you notice ongoing symptoms that don’t go away on their own. These warning signs might include feeling unusually tired for weeks at a time, experiencing night sweats that soak through your clothing, losing weight without trying, or developing fevers without an obvious infection. Other reasons to talk to your doctor include noticing frequent nosebleeds, bleeding gums that happen easily, headaches that persist, vision problems that seem to worsen, or a tingling sensation in your fingers and toes that doesn’t improve.^[1][2]

Sometimes your primary care provider might notice unusual results during routine blood tests. If your blood work shows abnormal protein levels or low counts of different blood cells, your doctor may recommend further testing even if you feel perfectly fine. This is actually a positive situation because catching the disease early, before symptoms develop, allows doctors to monitor it carefully and start treatment only when truly necessary.^[2]

People with certain risk factors should be particularly attentive to changes in their health. If you are over 65 years old, have biological family members who had Waldenstrom’s macroglobulinaemia or other types of lymphoma (cancers affecting white blood cells), or have a condition called MGUS (monoclonal gammopathy of undetermined significance, where abnormal proteins appear in blood but don’t cause problems yet), you may benefit from regular check-ups that include blood tests.^[2]

Diagnostic Methods

Diagnosing Waldenstrom’s macroglobulinaemia involves several steps, starting with simpler tests and moving to more detailed examinations if needed. Your healthcare team uses these tests not only to confirm whether you have the disease but also to understand how much it has progressed and whether it’s affecting your organs.

Physical Examination and Medical History

Every diagnosis begins with your doctor asking detailed questions about your symptoms and examining you physically. During this exam, your doctor will feel areas of your body to check for swollen lymph nodes (small bean-shaped organs that are part of your immune system), particularly around your neck, under your arms, and in your groin. They will also check whether your spleen or liver feels larger than normal by gently pressing on the left and right sides of your abdomen. An enlarged spleen can cause a feeling of fullness or discomfort under your ribs on the left side.^[1][11]

Blood Tests

Blood tests are the cornerstone of diagnosing Waldenstrom’s macroglobulinaemia. These tests reveal crucial information about what’s happening inside your body at a cellular level. Your doctor will order several different blood analyses, each looking at specific aspects of your blood composition.^[11]

A complete blood count, often called CBC, measures the numbers of different types of blood cells. In Waldenstrom’s macroglobulinaemia, you might have fewer red blood cells than normal, which leads to anemia (low red blood cell count causing tiredness). You might also have low counts of white blood cells, making it harder to fight infections, or low platelets (tiny cells that help blood clot), which can cause easy bruising or bleeding. These problems happen because cancer cells crowd out healthy cells in the bone marrow, the spongy tissue inside bones where blood cells are made.^[2]

Another critical blood test checks for abnormal proteins. In Waldenstrom’s macroglobulinaemia, cancer cells produce large amounts of a protein called immunoglobulin M, or IgM for short. This protein is normally made by healthy immune cells to fight infections, but cancer cells make far too much of it. Doctors use tests like protein electrophoresis and immunofixation to identify and measure this IgM protein in your blood. High levels of IgM are a hallmark sign of this disease.^[2][11]

Additional blood tests check how well your organs are functioning, particularly your kidneys and liver. Sometimes the excess IgM protein can harm these organs, so knowing their condition helps doctors plan appropriate care. Blood tests can also measure the thickness of your blood, which is important because too much IgM can make blood syrupy and slow-moving, leading to serious complications.^[11]

Bone Marrow Biopsy

A bone marrow biopsy is a key test for confirming Waldenstrom’s macroglobulinaemia. During this procedure, a doctor takes a small sample of bone marrow, usually from your hipbone. You’ll receive local anesthesia to numb the area, and sometimes sedation to help you relax. The doctor inserts a special needle through your skin and into the bone to extract a tiny amount of marrow tissue.^[11]

The collected sample goes to a laboratory where specialists examine it under a microscope. They look for abnormal white blood cells that characterize Waldenstrom’s macroglobulinaemia. These cancer cells often have features of both lymphocytes (one type of white blood cell) and plasma cells (another type that normally makes antibodies). The laboratory can also perform genetic tests on these cells to look for specific mutations, such as changes in genes called MYD88 and CXCR4, which are found in most people with this disease. Understanding these genetic changes can help predict how the disease might behave and guide treatment decisions.^[2][6]

While a bone marrow biopsy might sound uncomfortable, most people tolerate it well. You may feel pressure during the procedure and some soreness afterward, similar to a deep bruise, but this typically fades within a few days.

Imaging Tests

Imaging tests create pictures of the inside of your body and help doctors see if cancer has spread beyond the bone marrow to other areas. These tests are particularly useful for checking lymph nodes, the spleen, and other organs.^[11]

CT scans (computed tomography) use X-rays taken from multiple angles to create detailed cross-sectional images of your body. A CT scan can show whether lymph nodes are enlarged or if organs like the spleen or liver have grown larger than normal. Sometimes you’ll drink a contrast liquid or receive an injection of contrast dye before the scan to make certain tissues show up more clearly in the images.

PET scans (positron emission tomography) involve injecting a small amount of radioactive sugar into your bloodstream. Cancer cells, which use more energy than normal cells, absorb more of this sugar and show up as bright spots on the scan. This helps doctors identify areas where cancer might be active.^[11]

These imaging tests are painless, though some people feel anxious lying still inside the scanning machines. The radiation exposure from these tests is generally low and considered safe for the medical information they provide.

Additional Testing for Complications

If your doctor suspects that excess IgM protein is causing complications, additional tests might be necessary. When blood becomes too thick from high IgM levels, a condition called hyperviscosity syndrome develops. This can be measured through blood viscosity tests. If hyperviscosity is confirmed, you might need a procedure called plasmapheresis to remove excess protein from your blood before or during treatment.^[9]

Doctors may also test for related conditions. Some people with Waldenstrom’s macroglobulinaemia develop cryoglobulinemia, where proteins in blood clump together when exposed to cold temperatures, causing pain and color changes in hands and feet. Others might develop amyloidosis, where abnormal proteins deposit in organs like the heart, kidneys, or lungs. Tests for these complications include special blood tests, urine tests, and sometimes tissue biopsies from affected organs.^[2]

Diagnostics for Clinical Trial Qualification

Clinical trials test new treatments for Waldenstrom’s macroglobulinaemia and often require participants to meet specific diagnostic criteria. Understanding these requirements can help you determine whether joining a clinical trial might be an option for you.

Standard Diagnostic Criteria for Trial Enrollment

Most clinical trials require clear confirmation of Waldenstrom’s macroglobulinaemia through a bone marrow biopsy showing the characteristic cancer cells. The biopsy results must demonstrate lymphoplasmacytic lymphoma (another name for this disease) with a certain percentage of bone marrow occupied by abnormal cells. Typically, trials require at least 10% of bone marrow to contain these cells, though this threshold varies between studies.^[8]

Blood tests showing elevated IgM protein levels are almost always required. Different trials set different minimum IgM levels for participation. Some studies focus on people with high IgM levels who are experiencing symptoms, while others might accept participants with lower levels if they have other disease-related problems.

Genetic Testing for Trial Matching

Many modern clinical trials categorize patients based on genetic mutations found in their cancer cells. The MYD88 mutation, present in over 90% of people with Waldenstrom’s macroglobulinaemia, is particularly important. Some trials specifically enroll patients who have this mutation, while others study treatments for the minority of patients who don’t have it. Similarly, the CXCR4 mutation, found in about 40% of cases, may determine eligibility for certain studies.^[2][6]

If you’re considering a clinical trial, ask your doctor whether genetic testing of your cancer cells has been done. If not, this testing can usually be performed on stored tissue from your bone marrow biopsy, so you wouldn’t necessarily need another biopsy.

Treatment History and Disease Status

Clinical trials often have strict requirements about previous treatments. Some trials only accept “treatment-naïve” patients, meaning people who have never received treatment for Waldenstrom’s macroglobulinaemia. These trials test whether new therapies work as initial treatments. Other trials specifically study “relapsed” or “refractory” disease, enrolling people whose disease has come back after treatment or didn’t respond to previous therapies.^[9]

To qualify for trials, you’ll need detailed records of any previous treatments, including medication names, doses, duration of treatment, and how well the treatment worked. Doctors use standard response criteria to classify how your disease responded, with categories like complete response, partial response, or no response. These classifications are based on measurements of IgM levels, bone marrow biopsy results, and imaging scans done before, during, and after treatment.

Baseline Health Assessments

Before joining a clinical trial, you’ll undergo comprehensive testing to establish your baseline health status. This ensures that you’re healthy enough to participate safely and provides reference points for monitoring how treatment affects you.

These baseline assessments typically include complete blood counts, kidney and liver function tests, and tests to check your heart health such as an electrocardiogram. Many trials exclude people with severe heart, kidney, or liver problems because experimental treatments might pose additional risks. However, each trial has different criteria, and some specifically study treatments for patients with these complications.

Imaging studies at baseline document the extent of disease before treatment starts. CT or PET scans show measurable disease in lymph nodes or organs, which can be compared to scans taken later to evaluate whether treatment is working.

Performance Status Evaluation

Clinical trials assess your general physical condition using standardized scoring systems. The most common is the performance status scale, which rates your ability to carry out daily activities. Scores range from fully active and able to work normally, to requiring significant care and spending most time in bed. Most trials require participants to have relatively good performance status, though some studies specifically investigate treatments for people with poorer functional abilities.

This evaluation isn’t meant to exclude people but rather to match participants with appropriate studies and ensure their safety. Your healthcare team can help you understand which trials might be suitable based on your current physical condition and overall health.